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Endotoxin-induced tumor necrosis has been shown to be mediated by a factor termed 
tumor necrosis factor (TNF). The biochemical nature, source, and mode of induction 
of T N F have been clarified. T N F is a mediator of activated macrophages that is released 
into the supernatant by these cells after their stimulation with endotoxin. A number of 
biologic functions of T N F other than its tumoricidal activity have been demonstrated. 
In vivo, T N F induces reactions similar to those induced by endotoxin. Hypothermia, 
elevated hematocrit and plasma lactate levels, and reduced plasma glucose levels have 
been measured in mice injected with TNF. These reactions typically occur soon after en-
dotoxin injection and are induced with purified recombinant T N F in mice that exhibit 
a low response to endotoxin. No TNF-induced production of interleukin 1 (which can 
induce similar effects) was detected in macrophage/monocyte cultures. Therefore, T N F 
appears to mediate endotoxin effects directly. 
Bacterial endotoxin has been shown to exert detri-
mental as well as beneficial effects in various ex-
perimental models in which different means were 
used for compromising the host. Toxic effects, fe-
ver, tumor regression, and enhancement of non-
specific resistance to infection and lethal irradiation 
are some examples o f endotoxin reactions. In recent 
years it has become apparent that some of these 
effects are accomplished by the interaction of endo-
toxin with its main target cell — the macrophage. Sen-
sitivity to endotoxin depends on the state o f acti-
vat ion o f the host's lymphoreticular system. 
Endotox in is extremely toxic for activated macro-
phages in BCG-infected animals [1] or for macro-
phages that have been activated in vitro [2]. Also , 
release o f mediators is qualitatively and quantita-
tively related to the degree of macrophage activa-
t ion [3]. Thus, the status of the reactivity o f macro-
phages is o f great importance to the lethal effects 
o f endotoxin. M a n y investigations have addressed 
the role of macrophages and their release of humoral 
mediators in endotoxic effects. 
Tumor necrosis factor ( T N F ) is a protein released 
by activated macrophages upon their stimulation 
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with bacterial lipopolysaccharide (LPS) [2]. The mo-
lecular cloning of the c D N A for T N F and the ex-
pression of this c D N A in Escherichia coli [4-6] have 
made available large amounts o f the recombinant 
protein for biologic research. Before the nature of 
the T N F molecule was known, T N F was defined by 
its tumor necrotizing activity in vivo and its tumor 
cell cytotoxic activity in vitro. Investigations of the 
biologic activities o f purified recombinant T N F re-
vealed that T N F not only serves as a cytotoxic mol -
ecule for tumor cells but also has an array of effects 
on different target cells. Compar i son of the amino 
acid sequences of T N F and cachectin, another 
monokine that is secreted in response to endotoxin 
or other bacterial and protozoal products, revealed 
the identity o f the two proteins [7], The activity o f 
cachectin leads to a decrease in lipoprotein lipase ac-
tivity and to the metabolic derangements that occur 
during infection and cachexia [8]. Antibodies to the 
purified cachec t in /TNF molecule inhibited the le-
thal activity o f endotoxin, a finding indicating a role 
for this mediator in endotoxic effects [9, 10]. 
Direct analysis o f the biologic effects o f T N F in 
different test systems further demonstrated the im-
portance of T N F in inflammatory events. Produc-
tion of prostaglandin E 2 and collagenase by human 
synovial cells and dermal fibroblasts [11]; induction 
of procoagulant activity and tissue factor by the 
endothelium; and propagation o f the coagulation 
pathway leading to the deposition of f ibr in [12], 
bone resorption, and inhibi t ion of bone formation 
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[13] are effects of T N F typical for inflammatory 
responses. 
T N F also exerts biologic effects on the neutrophil, 
another cell that plays a central role in inflamma-
tory processes. Enhancement of phagocytic and 
antibody-dependent cytotoxic activity [14] and of ad-
herence of neutrophils to endothelial cells [15] in 
response to T N F has been reported. Furthermore, 
T N F is an important immunologic mediator. It en-
hances eosinophil toxicity [16] and increases surface 
expression of class I major histocompatibility com-
plex antigens on endothelial cells and dermal fibro-
blasts [17]. 
In this communication we compare some effects 
of recombinant T N F in vivo with typical effects of 
endotoxin. T N F and L P S induced similar ther-
moregulatory effects and changes in blood para-
meters when administered iv to mice. T N F induced 
the observed effects rather directly and not via the 
induction of interleukin 1 (IL-1) secretion, since T N F 
did not induce IL-1 production in our macrophage 
culture systems. These observations, therefore, fur-
ther support the notion that T N F is involved in en-
dotoxin reactions and may act as an endogenous 
mediator of endotoxin. 
Materials, Methods, and Results 
In an effort to show the connection between L P S 
and T N F , we measured some parameters that change 
significantly after iv administration of bacterial L P S . 
These changes were compared with the effects in -
duced by the iv administration of purified recom-
binant human T N F . The T N F preparation was kind-
ly provided by B A S F (Ludwigshafen, F R G ) and 
Table 1. Blood parameters in mice after the injection 
of bacterial lipopolysaccharide (LPS) or tumor necrosis 
factor (TNF). 
Hematocrit Glucose Lactate 
(%) (mg/100 ml) (mg/100 ml) 
Stimulus ± SD ± SD ± SD 
Control 42.3 ± 1.7 82.3 ± 23.2 62.9 ± 12.1 
LPS 56.6 ± 7.3 32.9 ± 11.5 58.6 ± 8.9 
T N F 63.0 ± 1.0 14.8 ± 0.4 85.3 ± 7.9 
N O T E . Each group comprised three age-, sex-, and weight-
matched C 3 H / H e mice. Animals were injected iv with LPS 
(Salmonella montevideo strain SH94, 200 ng), T N F (60 ng), or 
PBS (control, 100 Hematocrit, plasma lactate, and plasma 
glucose levels were determined from blood samples taken 6 h 
after injection. 
contained <0.03 ng of endotoxin/mg of protein, as 
determined in the limulus lysate assay. When T N F 
was injected iv into mice at a concentration o f 40 
\xg per animal (2 mg/kg) , the first symptoms resem-
bled the toxic effects seen after endotoxin applica-
tion; within hours ruffled fur, diarrhea, hypother-
mia, and loss of body weight were noted. The extent 
of the observed effects was dependent on the mouse 
strain used. The sensitivity o f a given mouse strain 
( C 3 H / H e or C 3 H / H e J ) differed considerably from 
experiment to experiment. Therefore, only values ob-
tained in the same experiment were compared. 
Changes in Blood Parameters 
B l o o d parameters of LPS-sensitive animals ( C 3 H / 
He) that had received 100 u.g of L P S {Salmonella 
montevideo strain SH94 prepared according to the 
modified phenol-water extraction method [18]) iv 
changed significantly within 6 h. Animals were bled 
from the retroorbital plexus at intervals, and b lood 
or plasma parameters were enzymatically determined 
with use of commercial kits (GlucoQuant and M o n o -
test-Lactate kit, both from Boehringer, Mannheim, 
F R G ) . Hematocrit levels increased within 30 min (ta-
ble 1). Plasma glucose levels dropped during the first 
6 h after administration o f L P S . Plasma lactate lev-
els were not changed in the animals injected with L P S 
despite the fact that very large and almost lethal 
amounts of L P S are reported to enhance the lactate 
levels [19]. Similar results were obtained in mice in -
jected with T N F . After T N F injection the plasma 
glucose levels were even lower than those after L P S 
injection, and the plasma lactate levels were en-
hanced. The contaminating amount of endotoxin in 
the T N F preparation (<2 pg) was not able to induce 
these effects (data not shown). Also , mice with a low 
response to L P S ( C 3 H / H e J strain) reacted to T N F 
with the same changes as C 3 H / H e mice (data not 
shown), a finding that indicates these effects were 
due to T N F itself. 
Thermoregulatory Activity of TNF 
Mice react with hypothermia when injected with 
L P S , whereas most other species develop a fever [20]. 
A s shown in figure 1, T N F caused a hypothermic 
reaction in C 3 H / H e as well as C 3 H / H e J mice. The 
rectal temperature of the animals was determined 
with an electronic temperature probe (Haake DT-
10, Karlsruhe, F R G ) at different times after iv injec-
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Figure 1. Hypothermia in mice after injection with bac-
terial lipopolysaccharide (LPS) or tumor necrosis factor 
(TNF). Groups of three C 3 H / H e (——) or C 3 H / H e J 
( ) mice were injected with either LPS {Salmonella 
montevideo strain SH94, 100 \ig\ circles) or T N F (60 ng; 
squares) iv and their temperatures were determined at in-
tervals after injection. A l l three C3H/He mice injected with 
T N F died within 24 h (a). 
t ion o f either L P S or T N F . The TNF-induced hypo-
thermia was dose-dependent (data not shown), a 
finding that again indicates that T N F itself has a 
thermoregulatory activity similar to that of bacterial 
endotoxin. 
Lack of IL-1 Induction by TNF 
We tested whether T N F was able to induce IL-1 ac-
tivity in murine or human monocyte/macrophage 
cultures, since the thermoregulatory activity o f en-
dotoxin has been shown to be mediated by endoge-
nous pyrogen/IL-1. Mur ine peritoneal exudate cells 
( P E C ) were induced by the injection of 1 ml o f P B S 
ip 16 h before the collection o f the exudate. The ad-
herent fraction was cultured in the presence o f ei-
ther L P S or T N F or without any stimulating agent. 
Cell-free supernatants were tested after 24 h for their 
costimulator activity in a standard IL-1 assay. 
C 3 H / H e J thymocytes (3 x 105) were cultured in the 
presence of suboptimal concentrations o f phyto-
hemagglutinin (50 ng/ml; P H A - M , Sigma, Deisen-
hofen, F R G ) and with serial dilutions o f the super-
natants. IL-l-dependent proliferation o f the 
thymocytes was determined by counting the incor-
porated radioactivity at 72 h after a 16-h pulse with 
1 p,Ci of [ 3H]thymidine (Amersham, Braunschweig, 
F R G ; specific activity, 50 C i / m M ) . Only weak IL-1 
Table 2. Induction of interleukin 1 (IL-1) in murine 
peritoneal exudate cell (PEC) cultures. 
Mouse strain, stimulus IL-1 
(Hg/ml)* (U/ml)t 
C 3 H / H e 
L P S , 10 24 
T N F 
10 6 
1 <4 
0.1 <4 
None <4 
C 3 H / H e J 
T N F 
10 <4 
1 <4 
0.1 <4 
None <4 
* Adherent P E C (2 x 106) from either C 3 H / H e or C3H/HeJ 
mice were cultured in the presence of either lipopolysaccharide 
(LPS; Salmonella montevideo strain SH94, 10 ng/ml), tumor 
necrosis factor (TNF; 0.1-10 ng/ml), or no stimulus in a volume 
of 1 ml for 24 h. 
t IL-1 units were determined as the reciprocal dilution of the 
cell-free culture supernatant that induced [3H]thymidine incor-
poration 2.5-fold higher than the background. 
activity was determined in supernatants of T N F -
stimulated C 3 H / H e - P E C (table 2). L P S , however, 
induced significant IL-1 activity under these condi-
tions. N o IL-1 activity was detected when P E C of 
C 3 H / H e J mice (low response to endotoxin) were 
stimulated with T N F . 
H u m a n peripheral b lood mononuclear lympho-
Table 3. Induction of interleukin 1 (IL-1) by bacterial 
lipopolysaccharide (LPS) or tumor necrosis factor (TNF) 
in human monocyte cultures. 
IL-1 
Stimulus* (U/ml)t 
LPS , 10 ng/ml 64 
T N F 
10 ng/ml <4 
1 ^ig/ml <4 
100 ng/ml <4 
10 ng/ml <4 
1 ng/ml <4 
None <4 
* Adherent human mononuclear cells (3 x 105) were cultured 
in the presence of L P S (Salmonella typhimurium strain 0901, 
Difco, Detroit), of T N F at the indicated concentrations, or with 
no stimulus in a volume of 1 ml for 24 h. 
t IL-1 units were determined as indicated in table 2. 
cytes (consisting of ~ 9 5 % monocytes) that had been 
purified by centrifugation over ficoll-Hypaque [21] 
and adherence to plastic did not produce IL-1 activ-
ity when stimulated with T N F at concentrations 
ranging from 1 n g / m l to 10 jug/ml (table 3). In fur-
ther experiments we tested whether T N F was able 
to modulate LPS-induced IL-1 activity and whether 
inhibitory activities were generated that could inter-
fere with the IL-1 test system. However, T N F nei-
ther modulated the induction of IL-1 production nor 
interfered with the thymocyte costimulator test sys-
tem (data not shown). F rom these results we con-
cluded that T N F per se is an endogenous ther-
moregulatory mediator similar to IL-1 and that it 
acts on the thermoregulatory system without the 
prior induction of IL-1 production by monocytes. 
Conclusions 
The effect of macrophages in sepsis and in inflam-
matory responses is mediated by a large array of 
secreted products. The macrophage is the most im-
portant target cell for endotoxin, and the lethal ef-
fects of endotoxin are dependent on the stage of ac-
tivation of the macrophages. This indicates the 
involvement of endotoxin-induced monokines in the 
toxic effects of endotoxin. There is strong evidence 
that T N F , like IL-1, is an important mediator of en-
dotoxic effects. (/) It was demonstrated by Beutler 
et al . [9] that reduction of endotoxin-caused lethal-
ity in mice can be achieved with antibodies to T N F . 
(2) In this paper we discuss some endotoxin-like reac-
tions in vivo (changes in blood parameters and in-
duction of hypothermia) that can be evoked by in-
jection of T N F alone. (3) It was shown that T N F 
production was not induced in endotoxin-tolerant 
mice [3]. In endotoxin-tolerant mice other media-
tors, such as IL-1, were generated in lower amounts 
than in nontolerant controls, but no T N F activity 
could be detected. (4) Preliminary data by Aderka 
et al . [22] demonstrated that peripheral blood mono-
cytes of patients with cancer spontaneously produced 
larger amounts of T N F than did cells of controls, 
a finding indicating that T N F may also mediate 
cachexia in cancer. 
The induction of IL-1 activity by T N F in endo-
thelial cells has been described by several investiga-
tors [23, 24]. Highest levels of IL-1 activity were de-
tected when endothelial cells were exposed to T N F 
for >20 h. However, we did not detect any costimu-
lator activity generated in murine or human mono-
cyte/macrophage cultures after 24 h when the in-
fluence of endotoxin was excluded by the use of P E C 
from C 3 H / H e J mice or by the selection of culture 
medium and fetal calf serum lacking IL- l - inducing 
activity [25]. Whether IL-1 activity in macrophages 
can be induced by T N F under modified experimen-
tal conditions or is induced in amounts smaller than 
those detectable in the costimulator assay needs to 
be clarified. Hybr idizat ion experiments for the de-
tection of TNF-induced IL-1 m R N A are currently 
being done. From the results obtained in this inves-
tigation, it became obvious that T N F —in contrast 
to L P S —did not induce the production of signifi-
cant titers of IL-1 in cultures of murine adherent 
P E C s or human monocytes. Therefore, T N F seems 
to be directly responsible for the thermoregulatory 
changes measured 2-3 h after T N F application. 
From the literature and from the data presented 
in this report, it becomes clear that the tumor-
necrotizing action describes an important function 
of T N F . However, the name tumor necrosis factor 
is historical and may be misleading since it falls short 
of indicating the potential importance of this 
monocyte-derived mediator. Considering all the bio-
logic activities attributed to T N F , one can rank T N F 
among mediators such as IL-1 and interferon-y in 
its ability to modulate the immune system and af-
fect the host organism. 
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